
Iodixanol Injectable Solution Suppliers & Bulk Manufacturers
Available Forms: Injectable Solution
Available Strengths: 270 mg/mL, 320 mg/mL, 370 mg/mL
Reference Brands: Visipaque(US & EU)
Category: Contrast Agent
Iodixanol Injectable Solution is available in Injectable Solution and strengths such as 270 mg/mL, 320 mg/mL, 370 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Iodixanol Injectable Solution is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Iodixanol Injectable Solution can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Iodixanol, marketed as Visipaque, is approved in the US by the FDA and in the EU via EMA for use as a contrast agent in X-ray and CT imaging procedures. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Supporting regional adherence supports swift approval, safe administration, and global availability of iodixanol, facilitating effective diagnostics worldwide.
Frequently Asked Questions
Related Products
Sulfur Hexafluoride Microbubbles Injection
Strength:
60.7mg
Form: injection
Reference Brands: SonoVue(EU)
View DetailsBarium Sulfate Suspension
Strength:
30% w/v , 40% w/v
Form: Powder for oral suspension
Reference Brands: Gastroview, Osmo-Maq, FlexiView(US)
View DetailsGadoxetate Injectable Solution
Strength:
0.25 mmol/mL
Form: Injectable Solution
Reference Brands: Eovist(US)
View DetailsGadofosveset Injectable Solution
Strength:
0.03 mmol/kg
Form: Injectable Solution
Reference Brands: Ablivar(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers